// App-Quantinova.ai

100 : Prospective analysis of prostate cancer (PC) circulating tumor cells (CTCs) to predict response to docetaxel (DOC) chemotherapy.

Researchers

Presenter

  • David M. Nanus

Principal Investigators

  • Matthew Loftus

  • Naveed Hassan Akhtar

  • Scott T. Tagawa

  • Himisha Beltran

  • Oscar B. Goodman

  • Xi Kathy Zhou

  • Neil Harrison Bander

  • Paraskevi Giannakakou

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Nevada Cancer Institute Medical Group, Las Vegas, NV

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Folate Hydrolase 1

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved